Is SPRAVATO® FDA-approved?
Yes. SPRAVATO® (esketamine) received FDA approval in 2019 specifically for the treatment of adults with treatment-resistant depression. Its approval was based on a robust body of clinical research supporting its safety and efficacy in individuals who have not responded adequately to traditional antidepressant therapies.
Click the button below to see if Spravato is a good fit for you.